Pune, Maharashtra -- (SBWire) -- 02/19/2019 --This Fact.MR report on the global peptide based hematological disorders therapeutics market forecasts that the global peptide based hematological disorders therapeutics market will touch a value of nearly US$ 530 Mn in the year 2022 and grow at a robust CAGR during the assessment period.
North America Market Set to Dominate the Global Peptide Based Hematological Disorders Therapeutics Market in Terms of Revenue
The market in North America is set to dominate the global peptide based hematological disorders therapeutics market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America peptide based hematological disorders therapeutics market is the most attractive market, growing at a robust CAGR over the assessment period.
Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=189
Icatibant Segment Poised to Touch a Value of Nearly US$ 410 Mn in 2022
As per the forecast of Fact.MR, the icatibant segment is expected to reach a value of nearly US$ 410 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Icatibant segment is expected to account for more than three-fourth of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.
Hospital Pharmacies Segment to exhibit a CAGR of 7.4% During the Assessment Period
As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 260 Mn in the year 2022. This represents a CAGR of 7.4% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.
Competition Tracking
The report also profiles companies that are expected to remain active in the expansion of global peptide based hematological disorders therapeutics market through 2022, which includes Shire plc.
Due to the advances in technology, the manufacturers and suppliers are encouraged to seek novel methods for peptide manufacturing, which is bound to improve the production of longer and complex chain of peptides and reduce the cost of production. Moreover, due to the automation of instruments, with improvements in the purification process and reduction in the total waste generated, are the driving factors triggering the growth of the global peptide therapeutics market. However, the synthesis and purification of long peptides is challenging for the manufacturers. Also, the rise in modifications and the addition of more unnatural amino acids have further increased the complications in peptide synthesis. This makes the manufactures of peptides difficult, and therefore the gap between demand and supply is increasing. Also, the manufacturing of peptides is a costly process, which hampers the growth of the global peptide therapeutics market.
Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=189
Detailed TOC of Global Peptide Based Hematological Disorders Therapeutics Market by Manufacturers, Regions, Type and Application, Forecast to 2022
1. Global Peptide Based Hematological Disorders Therapeutics Market - Executive Summary
2. Global Peptide Based Hematological Disorders Therapeutics Market Overview
2.1. Introduction
2.1.1. Global Peptide Based Hematological Disorders Therapeutics Market Taxonomy
2.1.2. Global Peptide Based Hematological Disorders Therapeutics Market Definition
2.2. Global Peptide Based Hematological Disorders Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Peptide Based Hematological Disorders Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Hematological Disorders Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region
Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=189
3. Global Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast By Drug
3.1. Global Peptide Based Hematological Disorders Therapeutics Market Size and Forecast By Drug, 2012-2022
3.1.1. Icatibant Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Ecallantide Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
4. Global Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast By Distribution Channel
4.1. Global Peptide Based Hematological Disorders Therapeutics Market Size and Forecast By Distribution Channel, 2012-2022
4.1.1. Hospital Pharmacies Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Retail Pharmacies Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Online Pharmacies Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
Access This Report @ https://www.factmr.com/checkout/189/S
5. Global Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast By Region
5.1. Global Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.1. North America Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.1.1. Revenue (US$ Mn) Comparison, By Drug
5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.2. Latin America Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.2.1. Revenue (US$ Mn) Comparison, By Drug
5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.3. Europe Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.3.1. Revenue (US$ Mn) Comparison, By Drug
5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.4. Japan Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.4.1. Revenue (US$ Mn) Comparison, By Drug
5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.5. APEJ Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.5.1. Revenue (US$ Mn) Comparison, By Drug
5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.6. MEA Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.6.1. Revenue (US$ Mn) Comparison, By Drug
5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel
And Continue...
List of Figures, Tables and Charts Available in Global Peptide Based Hematological Disorders Therapeutics Market 2017 by Manufacturers, Regions, Type and Application, Forecast to 2022
TABLE 1 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), 2012-2016
TABLE 2 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), 2017-2022
TABLE 3 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global Icatibant Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global Icatibant Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global Icatibant Segment Market Share, By Region 2012-2016
TABLE 7 Global Icatibant Segment Market Share, By Region 2017-2022
TABLE 8 Global Icatibant Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global Ecallantide Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global Ecallantide Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global Ecallantide Segment Market Share, By Region 2012-2016
TABLE 12 Global Ecallantide Segment Market Share, By Region 2017-2022
TABLE 13 Global Ecallantide Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 15 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2017-2022
And Continue...
FIG. 1 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), 2012-2016
FIG. 2 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn) Forecast, 2017-2022
FIG. 3 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 4 Global Icatibant Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 5 Global Icatibant Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 6 Global Icatibant Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 7 Global Ecallantide Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 8 Global Ecallantide Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 9 Global Ecallantide Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
And Continue...
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://theswisstimes.com
Market Research on Peptide Based Hematological Disorders Therapeutics Market 2018 and Analysis to 2028
Fact.MR has announced the addition of the “ Peptide Based Hematological Disorders Therapeutics Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2028"report to their offering.